Lv1
86 积分 2022-05-23 加入
Editor’s pick: Enlaza Therapeutics
14天前
已完结
An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation
1个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
1个月前
已完结
A methodological and mechanistic exploration to precise separation of circular RNA and nicked RNA by capillary gel electrophoresis with laser-induced fluorescence
1个月前
已完结
mRNA vaccines targeting HPV E6/E7: A new frontier in cervical cancer immunotherapy
1个月前
已完结
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
2个月前
已完结
APL-1702 long-term efficacy and safety for cervical histologic, high-grade squamous intraepithelial lesions: Results from a randomized, phase III, global study
2个月前
已完结
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
2个月前
已完结
A phospholipid-like charge-reversible lipid for PEG-free, stable, and low-inflammatory mRNA lipid nanoparticles
3个月前
已关闭
Strategies to reduce the risks of mRNA drug and vaccine toxicity
3个月前
已完结
皖公网安备34019202002308
